Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $271.03 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $149.19 | 7 | $0 (2021) |
| Exact Sciences Corporation | $82.08 | 5 | $0 (2024) |
| AbbVie Inc. | $39.76 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.46 | 3 | Exact Sciences Corporation ($51.46) |
| 2023 | $30.62 | 2 | Exact Sciences Corporation ($30.62) |
| 2021 | $125.89 | 7 | Amarin Pharma Inc. ($86.13) |
| 2020 | $63.06 | 3 | Amarin Pharma Inc. ($63.06) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Oncology | ||||||
| 03/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Oncology | ||||||
| 01/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Oncology | ||||||
| 04/25/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Oncology | ||||||
| 10/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Cardiovascular | ||||||
| 07/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Cardiovascular | ||||||
| 05/24/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Cardiovascular | ||||||
| 01/22/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiovascular | ||||||
| 01/18/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: Cardiovascular | ||||||
| 10/01/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiovascular | ||||||
| 08/03/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 101 | 166 | $38,860 | $14,514 |
| 2022 | 3 | 98 | 146 | $30,321 | $14,116 |
| 2021 | 6 | 195 | 244 | $44,423 | $20,095 |
| 2020 | 5 | 77 | 132 | $32,730 | $6,063 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 50 | 115 | $28,200 | $9,158 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 39 | 39 | $9,833 | $4,989 | 50.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $827.00 | $367.56 | 44.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 66 | 113 | $25,086 | $11,025 | 43.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 20 | 20 | $4,780 | $2,697 | 56.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 13 | $455.00 | $393.26 | 86.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 130 | $28,860 | $11,978 | 41.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 34 | 34 | $8,126 | $4,625 | 56.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 30 | 34 | $3,162 | $1,573 | 49.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 20 | $3,040 | $1,305 | 42.9% |
| 90674 | Vaccine for influenza derived from cell cultures for administration into muscle, 0.5 ml dosage, quadrivalent, , preservative and antibiotic free | Office | 2021 | 13 | 13 | $780.00 | $389.22 | 49.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $455.00 | $225.03 | 49.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 46 | $12,098 | $2,679 | 22.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 16 | 17 | $9,027 | $1,467 | 16.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 13 | $7,056 | $1,439 | 20.4% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 21 | 45 | $3,735 | $301.80 | 8.1% |
| 94016 | Physician interpretation and report of measurement and graphic recording of amount and speed of breathed air over 30-day period | Facility | 2020 | 11 | 11 | $814.00 | $176.37 | 21.7% |
About Dr. Charles Knight, MD
Dr. Charles Knight, MD is a Internal Medicine healthcare provider based in Pahrump, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306805064.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Knight, MD has received a total of $271.03 in payments from pharmaceutical and medical device companies, with $51.46 received in 2024. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($271.03).
As a Medicare-enrolled provider, Knight has provided services to 471 Medicare beneficiaries, totaling 688 services with total Medicare billing of $54,788. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hospitalist, Hospitalist
- Location Pahrump, NV
- Active Since 03/21/2006
- Last Updated 10/18/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1306805064
Products in Payments
- Vascepa (Drug) $149.19
- Cologuard Collection Kit (Device) $82.08
- UBRELVY (Drug) $39.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pahrump
Robert Vance, D.o, D.O
Internal Medicine — Payments: $4,039
Dr. Michael Reiner, M.d, M.D
Internal Medicine — Payments: $1,960
Dr. James Flowers, M.d, M.D
Internal Medicine — Payments: $1,935
Michele Griffith, Md, MD
Internal Medicine — Payments: $104.80